IDEXX LABORATORIES INC /DE Payments of Debt Issuance Costs
IDEXX LABORATORIES INC /DE (IDXX) reported Payments of Debt Issuance Costs of $3.74 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2026-02-20
- IDEXX LABORATORIES INC /DE payments of debt issuance costs for the quarter ending 2021-12-31 was $2.65M, a 8733.33% increase year-over-year.
- IDEXX LABORATORIES INC /DE payments of debt issuance costs for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- IDEXX LABORATORIES INC /DE payments of debt issuance costs for the quarter ending 2020-12-31 was $30.00K.
- IDEXX LABORATORIES INC /DE payments of debt issuance costs for the quarter ending 2020-09-30 was $7.00K, a 41.67% decline year-over-year.
- IDEXX LABORATORIES INC /DE payments of debt issuance costs for fiscal 2025 was $3.74M.
- IDEXX LABORATORIES INC /DE payments of debt issuance costs for fiscal 2024 was $0.00.
- IDEXX LABORATORIES INC /DE payments of debt issuance costs for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- IDEXX LABORATORIES INC /DE payments of debt issuance costs for fiscal 2022 was $435.00K, a 83.58% decline from fiscal 2021.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 6 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.74M 10-K · filed 2026-02-20 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-02-20 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-20 | |||
| 2022-12-31 | $435.00K 10-K · filed 2025-02-21 | |||
| 2021-12-31 | $2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $2.65M derived: sum of 2 quarters · filed 2024-02-22 | $2.65M 10-K · filed 2024-02-22 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $0.00 10-Q · filed 2021-11-02 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-07-30 | |||
| 2020-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $37.00K derived: sum of 2 quarters · filed 2023-02-16 | $5.03M derived: sum of 3 quarters · filed 2023-02-16 | $5.03M 10-K · filed 2023-02-16 |
| 2020-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $5.00M derived: sum of 2 quarters · filed 2021-11-02 | $5.00M 10-Q · filed 2021-11-02 | $5.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $4.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $4.99M 10-Q · filed 2021-07-30 | $4.99M derived: sum of 3 quarters · filed 2022-02-16 | $5.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $0.00 10-Q · filed 2020-04-30 | $0.00 derived: sum of 2 quarters · filed 2022-02-16 | $12.00K derived: sum of 3 quarters · filed 2022-02-16 | $124.00K derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $12.00K derived: sum of 2 quarters · filed 2022-02-16 | $124.00K derived: sum of 3 quarters · filed 2022-02-16 | $154.00K 10-K · filed 2022-02-16 |
| 2019-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $124.00K derived: sum of 2 quarters · filed 2020-10-29 | $154.00K 10-Q · filed 2020-10-29 | $154.00K derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $112.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $142.00K 10-Q · filed 2020-07-31 | $142.00K derived: sum of 3 quarters · filed 2021-02-12 | $142.00K derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $30.00K 10-Q · filed 2020-04-30 | $30.00K derived: sum of 2 quarters · filed 2021-02-12 | $30.00K derived: sum of 3 quarters · filed 2021-02-12 | $30.00K derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $0.00 derived: sum of 2 quarters · filed 2021-02-12 | $0.00 derived: sum of 3 quarters · filed 2021-02-12 | $0.00 10-K · filed 2021-02-12 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $0.00 derived: sum of 2 quarters · filed 2019-10-31 | $0.00 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-01 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-14 | |||
| 2016-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | -$1.00K derived: sum of 2 quarters · filed 2019-02-15 | -$1.00K derived: sum of 3 quarters · filed 2019-02-15 | $56.00K 10-K · filed 2019-02-15 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $0.00 derived: sum of 2 quarters · filed 2017-10-31 | $57.00K 10-Q · filed 2017-10-31 | $1.24M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $57.00K 10-Q · filed 2017-08-01 | $1.24M derived: sum of 3 quarters · filed 2018-02-16 | $1.31M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $57.00K 10-Q · filed 2017-04-28 | $1.24M derived: sum of 2 quarters · filed 2018-02-16 | $1.31M derived: sum of 3 quarters · filed 2018-02-16 | $1.35M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $1.25M derived: sum of 2 quarters · filed 2018-02-16 | $1.29M derived: sum of 3 quarters · filed 2018-02-16 | $1.38M 10-K · filed 2018-02-16 |
| 2015-09-30 | $72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $109.00K derived: sum of 2 quarters · filed 2016-11-01 | $199.00K 10-Q · filed 2016-11-01 | $248.00K derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-02 | $127.00K 10-Q · filed 2016-08-02 | $176.00K derived: sum of 3 quarters · filed 2017-02-17 | |
| 2015-03-31 | $90.00K 10-Q · filed 2016-04-29 | $139.00K derived: sum of 2 quarters · filed 2017-02-17 | ||
| 2014-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $1.41M 10-K · filed 2017-02-17 | ||
| 2014-09-30 | $1.36M 10-Q · filed 2015-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |